Sharp, a provider of pharmaceutical packaging and clinical services, has strengthened their clinical leadership team with the appointment of Robert Feltz as director of analytical and formulation services and Michael MacNeir as vice president, global business development.

Feltz has over 15 years of industry experience and moves to Sharp from Altasciences, where he was director of analytical services. He oversaw multiple drug candidates from pre-clinical to commercial launch. 

MacNeir joins Sharp from Marken, where he was vice president of commercial operations for the Americas. He brings over 14 years of clinical trial supply and operational experience.

“I am delighted to welcome Robert Feltz and Michael MacNeir to Sharp and I am confident they will make a significant contribution in shaping and growing our clinical business,“ said Robert O’Beirn, managing director of Sharp Clinical. “Their respective industry expertise will put us in a stronger position to deliver and expand our client-led clinical solutions, to better serve our customers and their patients.”